Engineered extracellular vesicles as multifunctional therapeutics for restoring periodontal homeostasis
Source abstract
Abstract
Periodontal homeostasis refers to the dynamic equilibrium between host defense, microbial control, and tissue remodeling in periodontal tissues. Periodontitis is a chronic inflammatory disease characterized by the destruction of periodontal tissues, in which periodontal homeostasis is disturbed. Although many strategies have been developed, treatment of periodontitis and restoration of periodontal homeostasis remain challenging. Extracellular vesicles (EVs) have emerged as a potential cell-free platform for therapeutic applications due to their intrinsic capacity for intercellular communication and biocompatibility. With the advances in engineering, EVs can be functionally tailored to exhibit improved stability, targeting, and bioactivity, attracting increasing attention as regulators for periodontal homeostasis. Accumulating evidence indicates that engineered EVs exert diverse regulatory effects in the periodontal microenvironment, including anti-bacterial activity, anti-inflammatory properties, immunomodulation, antioxidant protection, regulation of programmed cell fate, and promotion of regeneration. Such multifunctional properties enable engineered EVs to address periodontal dysregulation and contribute to the stabilization of tissue homeostasis. This review highlights recent advances in the application of engineered EVs in periodontal research, summarizes their emerging therapeutic roles across these biological domains, and emphasizes their potential as versatile modulators for the maintenance and restoration of periodontal homeostasis. STATEMENT OF SIGNIFICANCE: This review uniquely integrates recent progress in engineering extracellular vesicles (EVs) with biomaterial-based strategies to restore periodontal homeostasis, a perspective not comprehensively addressed in existing literature. By systematically analyzing approaches such as cargo and surface modification, scaffold incorporation, and artificial vesicle design, it highlights how engineered EVs overcome the limitations of native vesicles and achieve multifunctional regulation of microbial, immune, and regenerative processes. This work provides insights into the convergence of materials science, nanotechnology, and oral biology, and outlines future directions for translating engineered EVs into next-generation therapeutic platforms with broad relevance for biomaterial innovation and regenerative medicine.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Extracellular vesicles in disease · Oral microbiology and periodontitis research · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. The oral microbiota: dynamic communities and host interactions10.1038/s41579-018-0089-x ↗
2. Epithelial barrier and oral bacterial infection10.1111/prd.12094 ↗
3. MicroRNAs and periodontal homeostasis10.1177/0022034516685711 ↗
4. Analysis and biomedical applications of functional cargo in extracellular vesicles10.1021/acsnano.2c11298 ↗
5. Systematic review and sequential network meta-analysis on the efficacy of periodontal regenerative therapies10.1111/jcpe.13338 ↗
6. Periodontal bone-ligament-cementum regeneration via scaffolds and stem cells10.3390/cells8060537 ↗
7. Current status and future prospects of stomatology research10.1631/jzus.B2200702 ↗
8. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches10.1002/jev2.12404 ↗
9. Multi-prospects of bacterial extracellular vesicles in immune modulation, inflammation regulation, and periodontitis treatment10.1016/j.nantod.2024.102210 ↗
10. Mesenchymal stem cell-derived extracellular vesicles in periodontal bone repair10.1007/s00109-025-02513-4 ↗
11. Engineered extracellular vesicles for cancer therapy
12. Engineering exosomes and biomaterial-assisted exosomes as therapeutic carriers for bone regeneration10.1186/s13287-023-03275-x ↗
13. Engineered exosome for drug delivery: recent development and clinical applications10.2147/IJN.S444582 ↗
14. Exosomes and their bioengineering strategies in the cutaneous wound healing and related complications: current knowledge and future perspectives10.7150/ijbs.80430 ↗
15. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication10.1038/s41556-018-0250-9 ↗
16. The biology, function, and biomedical applications of exosomes10.1126/science.aau6977 ↗
17. Shedding light on the cell biology of extracellular vesicles10.1038/nrm.2017.125 ↗
18. Extracellular vesicle-based drug delivery systems in cancer10.1016/j.vesic.2024.100053 ↗
19. Engineered extracellular vesicles in female reproductive disorders10.1016/j.biopha.2023.115284 ↗
20. Liquid biopsies: microvesicles in cardiovascular disease10.1089/ars.2019.7922 ↗
21. Extracellular vesicle-mediated bidirectional communication between the liver and other organs: mechanistic exploration and prospects for clinical applications10.1186/s12951-025-03259-4 ↗
22. A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure10.1038/ncomms8439 ↗
23. Understanding the extracellular vesicle surface for clinical molecular biology10.1002/jev2.12260 ↗
24. Extracellular vesicles in periodontitis: pathogenic mechanisms and therapeutic potential10.2147/JIR.S504612 ↗
25. Lipids in extracellular vesicles: what can Be learned about membrane structure and function?10.1101/cshperspect.a041415 ↗
26. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes10.1073/pnas.1521230113 ↗
27. Inter-laboratory multiplex bead-based surface protein profiling of MSC-derived EV preparations identifies MSC-EV surface marker signatures10.1002/jev2.12463 ↗
28. Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells10.1074/jbc.M109.045427 ↗
29. Engineering strategies for apoptotic bodies10.1002/SMMD.20240005 ↗
30. Lipophilicity modulation of fluorescent probes for In situ imaging of cellular microvesicle dynamics10.1021/jacs.4c13516 ↗
31. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies10.1007/s11060-013-1084-8 ↗
32. Caspase-mediated cleavage of the centrosomal proteins during apoptosis10.1038/s41419-018-0632-8 ↗
33. Preclinical and clinical studies on the use of extracellular vesicles derived from mesenchymal stem cells in the treatment of chronic wounds10.1021/acs.molpharmaceut.3c01121 ↗
34. Advances in biological functions and applications of apoptotic vesicles10.1186/s12964-023-01251-9 ↗
35. The applications and potentials of extracellular vesicles from different cell sources in periodontal regeneration10.3390/ijms24065790 ↗
36. Mechanisms and clinical application potential of mesenchymal stem cells-derived extracellular vesicles in periodontal regeneration10.1186/s13287-023-03242-6 ↗
37. Periodontal ligament stem cells: regenerative potency in periodontium10.1089/scd.2019.0031 ↗
38. Effects of periodontal ligament stem cell-derived exosomes on osteoblastic proliferation, migration, differentiation, apoptosis, and signaling pathways10.1111/odi.14375 ↗
39. Effect of human periodontal ligament stem cell-derived exosomes on cementoblast activity10.1111/odi.14671 ↗
40. Rab27a-mediated extracellular vesicle secretion contributes to osteogenesis in periodontal ligament-bone niche communication10.1038/s41598-023-35172-x ↗
41. VDAC1-enriched apoptotic extracellular vesicles emerge as an autophagy activator orchestrating PDLSC-based bone regeneration10.1016/j.cej.2024.154625 ↗
42. Exosomes regulate interclonal communication on osteogenic differentiation among heterogeneous osteogenic single-cell clones through PINK1/Parkin-mediated mitophagy10.3389/fcell.2021.687258 ↗
43. Periodontal ligament cells-derived exosomes promote osteoclast differentiation via modulating macrophage polarization10.1038/s41598-024-52073-9 ↗
44. Extracellular vesicles suppress basal and lipopolysaccharide-induced nfκb activity in Human periodontal ligament stem cells10.1089/scd.2019.0021 ↗
45. Exosomal microRNA-155-5p from PDLSCs regulated Th17/treg balance by targeting sirtuin-1 in chronic periodontitis10.1002/jcp.28671 ↗
46. Exosomal miR-205-5p derived from periodontal ligament stem cells attenuates the inflammation of chronic periodontitis via targeting XBP110.1002/iid3.743 ↗
47. ApoEVs transfer mitochondrial component to modulate macrophages in periodontal regeneration10.1111/odi.15181 ↗
48. Inflammatory periodontal ligament stem cells drive M1 macrophage polarization via exosomal miR-143-3p-mediated regulation of PI3K/AKT/NF-κb signaling10.1093/stmcls/sxac087 ↗
49. Dental pulp stem cell-derived exosomes regulate anti-inflammatory and osteogenesis in periodontal ligament stem cells and promote the repair of experimental periodontitis in rats10.2147/IJN.S420967 ↗
50. Periodontitis-compromised dental pulp stem cells secrete extracellular vesicles carrying miRNA-378a promote local angiogenesis by targeting Sufu to activate the Hedgehog/Gli1 signalling10.1111/cpr.13026 ↗
51. Extracellular vesicles from dental pulp cells promote osteogenic differentiation in periodontal ligament cells10.1111/jre.13390 ↗
52. Exosomes from dental pulp cells attenuate bone loss in mouse experimental periodontitis10.1111/jre.12949 ↗
53. The proangiogenic effects of extracellular vesicles secreted by dental pulp stem cells derived from periodontally compromised teeth10.1186/s13287-020-01614-w ↗
54. Exosomes derived from dental pulp stem cells show different angiogenic and osteogenic properties in relation to the age of the donor10.3390/pharmaceutics14050908 ↗
55. SHED-derived exosomes improve the repair capacity and osteogenesis potential of hPDLCs10.1111/odi.14153 ↗
56. Odontogenesis-empowered extracellular vesicles safeguard donor-recipient stem cell interplay to support tooth regeneration10.1002/smll.202400260 ↗
57. Youthful small extracellular vesicles restore the function and reparative capacity of inflammatory-impaired periodontal ligament stem cells via delivering protein biglycan for bone regeneration10.1186/s12951-024-02752-6 ↗
58. Role of gingival mesenchymal stem cell exosomes in macrophage polarization under inflammatory conditions10.1016/j.intimp.2019.106030 ↗
59. Exosomes derived from human gingival mesenchymal stem cells attenuate the inflammatory response in periodontal ligament stem cells10.3389/fchem.2022.863364 ↗
60. Human gingival mesenchymal stem cell-derived exosomes cross-regulate the wnt/β-catenin and NF-κb signalling pathways in the periodontal inflammation microenvironment10.1111/jcpe.13798 ↗
61. Human bone marrow stromal cell exosomes ameliorate periodontitis10.1177/00220345221084975 ↗
62. First experimental study of the influence of extracellular vesicles derived from multipotent stromal cells on osseointegration of dental implants10.3390/ijms22168774 ↗
63. Apoptotic extracellular vesicles induced endothelial cell-mediated autologous stem cell recruitment dominates allogeneic stem cell therapeutic mechanism for bone repair10.1021/acsnano.3c11050 ↗
64. BMSC-derived ApoEVs promote craniofacial bone repair via ROS/JNK signaling10.1177/00220345211068338 ↗
65. Apoptotic extracellular vesicles alleviate pg-LPS induced inflammation of macrophages via AMPK/SIRT1/NF-κB pathway and inhibit adjacent osteoclast formation10.1002/JPER.21-0657 ↗
66. Adipose mesenchymal stem cell-derived exosomes ameliorate hypoxia/serum deprivation-induced osteocyte apoptosis and osteocyte-mediated osteoclastogenesis in vitro10.1016/j.bbrc.2018.11.109 ↗
67. Mesenchymal stem cells-derived extracellular vesicles protect against oxidative stress-induced xenogeneic biological root injury via adaptive regulation of the PI3K/Akt/NRF2 pathway10.1186/s12951-023-02214-5 ↗
68. Extracellular vesicles as therapeutic tools in regenerative dentistry10.1186/s13287-024-03936-5 ↗
69. Notch signaling in the dynamics of perivascular stem cells and their niches10.1002/sctm.21-0086 ↗
70. Advances in the research of immunomodulatory mechanism of mesenchymal stromal/stem cells on periodontal tissue regeneration
71. Exosomes derived from M0, M1 and M2 macrophages exert distinct influences on the proliferation and differentiation of mesenchymal stem cells10.7717/peerj.8970 ↗
72. Macrophage-derived exosomes rescue the TNF-ɑ-suppressed osteo-/cementogenic differentiation of hPDLCs10.1111/odi.14947 ↗
73. Exosomes secreted from M2-polarized macrophages inhibit osteoclast differentiation via CYLD10.1016/j.tice.2024.102645 ↗
74. M2 macrophage-derived exosomes enable osteogenic differentiation and inhibit inflammation in human periodontal ligament stem cells through promotion of CXCL12 expression10.1186/s12903-024-04831-4 ↗
75. Macrophage-derived mitochondria-rich extracellular vesicles aggravate bone loss in periodontitis by disrupting the mitochondrial dynamics of BMSCs10.1186/s12951-025-03178-4 ↗
76. Macrophages with different polarization phenotypes influence cementoblast mineralization through exosomes10.1155/2022/4185972 ↗
77. Apoptotic vesicles from macrophages exacerbate periodontal bone resorption in periodontitis via delivering miR-143-3p targeting Igfbp510.1186/s12951-024-02934-2 ↗
78. Macrophage-derived apoptotic vesicles regulate fate commitment of mesenchymal stem cells via miR15510.1186/s13287-022-03004-w ↗
79. Macrophage-derived apoptotic bodies impair the osteogenic ability of osteoblasts in periodontitis10.1111/odi.14808 ↗
80. T cell-derived apoptotic extracellular vesicles ameliorate bone loss via CD39 and CD73-mediated ATP hydrolysis10.2147/IJN.S491222 ↗
81. Dendritic cell-derived extracellular vesicles mediate mesenchymal stem/stromal cell recruitment10.1038/s41598-017-01809-x ↗
82. Dendritic cell derived exosomes loaded with immunoregulatory cargo reprogram local immune responses and inhibit degenerative bone disease in vivo10.1080/20013078.2020.1795362 ↗
83. Modulation of dendritic cells by microbiota extracellular vesicles influences the cytokine profile and exosome cargo10.3390/nu14020344 ↗
84. Effects of periodontal cells-derived extracellular vesicles on mesenchymal stromal cell function10.1111/jre.13171 ↗
85. Osteoblasts-derived exosomal lncRNA-MALAT1 promotes osteoclastogenesis by targeting the miR-124/NFATc1 signaling axis in bone marrow-derived macrophages10.2147/IJN.S395607 ↗
86. Osteoblast-derived matrix vesicles exhibit exosomal traits and a unique subset of microRNA: their caveolae-dependent endocytosis results in reduced osteogenic differentiation10.3390/ijms241612770 ↗
87. Extracellular vesicles derived from murine cementoblasts possess the potential to increase receptor activator of nuclear factor-κB Ligand-induced osteoclastogenesis10.3389/fphys.2022.825596 ↗
88. Osteoclast-derived exosomal miR-5134-5p interferes with alveolar bone homeostasis by targeting the JAK2/STAT3 axis10.2147/IJN.S413692 ↗
89. miR-124-3p increases in high glucose induced osteocyte-derived exosomes and regulates galectin-3 expression: a possible mechanism in bone remodeling alteration in diabetic periodontitis10.1096/fj.202000970RR ↗
90. Schwann cell-derived exosomes accelerate periodontal bone regeneration with osteogenesis, angiogenesis, and neurogenesis
91. Epithelial microvesicles promote an inflammatory phenotype in fibroblasts10.1177/0022034516633172 ↗
92. Effect of salivary exosomal miR-25-3p on periodontitis with insulin resistance
93. Artificial exosomes for translational nanomedicine10.1186/s12951-021-00986-2 ↗
94. Preconditioning and engineering strategies for improving the efficacy of mesenchymal stem cell-derived exosomes in cell-free therapy10.1155/2022/1779346 ↗
95. A large-scale investigation of hypoxia-preconditioned allogeneic mesenchymal stem cells for myocardial repair in nonhuman primates: paracrine activity without remuscularization10.1161/CIRCRESAHA.115.307516 ↗
96. Serum deprivation of mesenchymal stem cells improves exosome activity and alters lipid and protein composition10.1016/j.isci.2019.05.029 ↗
97. Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells10.1002/jor.21517 ↗
98. Advances in the application of extracellular vesicles derived from three-dimensional culture of stem cells10.1186/s12951-024-02455-y ↗
99. Optimizing therapeutic outcomes: preconditioning strategies for MSC-derived extracellular vesicles
100. Roles of extracellular vesicles in periodontal homeostasis and their therapeutic potential10.1186/s12951-022-01757-3 ↗